Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Pan Asian Microvent Tech (Jiangsu) Corporation (688386.SS)
Changzhou, CN
Pan Asian Microvent Tech (Jiangsu) Corporation specializes in the development, manufacturing, and distribution of microporous materials. Its product line encompasses expanded polytetrafluoroethylene (ePTFE) membranes and their various modified derivatives. The company was established on November 8, 1995, by founders Wei Ping Yao, Yun Zhang, Ming Zhi Yang, and Dong Wei Zou, and its principal office is situated in Changzhou, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.09% | -4.69% | +8.26% | -15.33% | +14.16% | -4.68% | +101.93% | +153.65% | +117.05% | +135.08% | +135.08% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2025-12 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+40.3% ★ Q1'26: +24.9% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+9.2% Q1'26: -44.1% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+5.8% Q1'26: -122.6% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+21.8% ★ Q1'26: +16.9% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+8.6% ★ Q1'26: +5.3% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+30.6% Q1'26: +34.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×3.40× Q1'26: 5.81× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|
| Revenue |
277.73M
est: 281.00M (-1.2%)
|
316.62M
est: 317.00M (-0.1%)
|
364.46M
est: 367.33M (-0.8%)
|
410.55M
est: 493.00M (-16.7%)
|
514.78M
est: 650.00M (-20.8%)
|
722.43M
est: 711.00M (+1.6%)
|
1.03B
1.03B – 1.03B
+45.4% YoY
|
1.41B
1.41B – 1.41B
+36.8% YoY
|
| EBITDA |
86.84M
est: 85.47M (+1.6%)
|
89.37M
est: 96.42M (-7.3%)
|
112.90M
est: 111.73M (+1.0%)
|
125.51M
est: 149.96M (-16.3%)
|
159.79M
est: 194.04M (-17.6%)
|
205.48M
est: 212.25M (-3.2%)
|
308.67M
308.67M – 308.67M
+45.4% YoY
|
422.11M
422.11M – 422.11M
+36.8% YoY
|
| EBIT |
66.67M
est: 64.28M (+3.7%)
|
64.49M
est: 72.51M (-11.1%)
|
85.06M
est: 84.02M (+1.2%)
|
91.41M
est: 112.77M (-18.9%)
|
125.58M
est: 145.76M (-13.8%)
|
157.15M
est: 159.43M (-1.4%)
|
231.86M
231.86M – 231.86M
+45.4% YoY
|
317.07M
317.07M – 317.07M
+36.8% YoY
|
| Net Income |
55.27M
est: 60.75M (-9.0%)
|
66.40M
est: 48.34M (+37.3%)
|
31.34M
est: 48.88M (-35.9%)
|
86.54M
est: 63.38M (+36.5%)
|
99.16M
est: 118.51M (-16.3%)
|
108.57M
est: 126.72M (-14.3%)
|
235.21M
235.21M – 235.21M
+85.6% YoY
|
351.90M
351.90M – 351.90M
+49.6% YoY
|
| SGA |
38.85M
est: 42.53M (-8.7%)
|
52.22M
est: 47.98M (+8.8%)
|
53.70M
est: 55.60M (-3.4%)
|
66.18M
est: 74.62M (-11.3%)
|
73.86M
est: 86.58M (-14.7%)
|
35.46M
est: 94.71M (-62.6%)
|
137.73M
137.73M – 137.73M
+45.4% YoY
|
188.35M
188.35M – 188.35M
+36.8% YoY
|
| EPS |
0.79
est: 0.87 (-9.2%)
|
0.95
est: 0.69 (+37.2%)
|
0.45
est: 0.70 (-35.7%)
|
1.24
est: 0.91 (+36.6%)
|
1.09
est: 1.30 (-16.2%)
|
1.19
est: 1.39 (-14.4%)
|
2.58
2.58 – 2.58
+85.6% YoY
|
3.86
3.86 – 3.86
+49.6% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | B- | 2/5 | 1/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-11 | B- | 2/5 | 1/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-08 | B- | 2/5 | 1/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-07 | B- | 2/5 | 1/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-06 | B- | 2/5 | 1/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-30 | C+ | 2/5 | 1/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C+ | 2/5 | 1/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C+ | 2/5 | 1/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C+ | 2/5 | 1/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C+ | 2/5 | 1/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Li Jiang | Accounting Supervisor, Chief Financial Officer & Director | — | female |
| Shaohua Wang | Board Secretary & Deputy GM | — | male |
| Wang Aiguo | Deputy GM & Director | — | male |
| Yun Zhang | Chairman of the Board & GM | — | male |
| Yuxin Wang | Director & Head of Internal Audit | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 688386.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
